Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry Involving Variants in Hypothalamic Genes Upstream or Downstream From the Melanocortin-4 Receptor (MC4R)

NCT03479437 is registered in ClinicalTrials.gov with Rhythm Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03479437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03479437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry Involving Variants in Hypothalamic Genes Upstream or Downstream From the Melanocortin-4 Receptor (MC4R)
Lead sponsor
Rhythm Pharmaceuticals, Inc.
Phase
Observational
Overall status
Completed
Start date
April 15, 2018
Completion date
December 1, 2020
Enrollment
303 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

genetic forms of extreme obesity